Evidence-Based Management of Rectal Cancer

  • Paul Rooney
  • Nagarajan Pranesh


The evidence base for the management of rectal cancer is now considerable. Randomized trials and other good quality studies have provided the clinician with a rationale for the management of most tumors. Malignancies whose distal margin is measured at 15 cm or less from the anal verge using a rigid sigmoidoscope are classified as rectal. This chapter will consider staging, adjuvant therapy, and surgery of rectal malignancy with special emphasis on supporting evidence in the surgical literature that should to inform management decisions.


Local Recurrence Rectal Cancer Total Mesorectal Excision Local Recurrence Rate Circumferential Resection Margin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007.Google Scholar
  2. 2.
    Sharma A, et al. Colorectal MDTs: the team’s perspective. Colorectal Dis. 2008;10(1):63–8.PubMedGoogle Scholar
  3. 3.
    Perretta S, Guerrero V, Garcia-Aguilar J. Surgical treatment of rectal cancer: local resection. Surg Oncol Clin N Am. 2006;15(1):67–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Bipat S, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – a meta-analysis. Radiology. 2004;232(3):773–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Puli SR, et al. Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review. Ann Surg Oncol. 2009;16(5):1255–65.PubMedCrossRefGoogle Scholar
  6. 6.
    Brown G, et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer. 2004;91(1):23–9.PubMedCrossRefGoogle Scholar
  7. 7.
    MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132–9.CrossRefGoogle Scholar
  8. 8.
    Birbeck KF, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449–57.PubMedCrossRefGoogle Scholar
  9. 9.
    Adam IJ, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707–11.PubMedCrossRefGoogle Scholar
  10. 10.
    Martling AL, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356(9224):93–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Chand M, Heald RJ. Laparoscopic rectal cancer surgery. Br J Surg. 2011;98(2):166–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Kapiteijn E, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.PubMedCrossRefGoogle Scholar
  13. 13.
    Sebag-Montefiore D, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Quirke P, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Graf W, et al. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol. 1997;43(2):133–7.PubMedCrossRefGoogle Scholar
  16. 16.
    NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444–50.Google Scholar
  17. 17.
    Sauer R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Bosset JF, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Gerard JP, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24(28):4620–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Kuo LJ, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum. 2005;48(1):23–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Guillem JG, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg. 2005;241(5):829–36; discussion 836–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Beddy D, et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2008;15(12):3471–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Mignanelli ED, et al. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum. 2010;53(3):251–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Callender GG, et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010;17(2):441–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Habr-Gama A, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–7; discussion 717–8.PubMedGoogle Scholar
  26. 26.
    Habr-Gama A, et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys. 2008;71(4):1181–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Hiotis SP, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg. 2002;194(2):131–5; discussion 135–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Blomqvist L, Glimelius B. The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncol. 2008;47(1):5–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Marijnen CA, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20(3):817–25.PubMedCrossRefGoogle Scholar
  30. 30.
    Pollack J, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg. 2006;93(12):1519–25.PubMedCrossRefGoogle Scholar
  31. 31.
    Marijnen CA, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005;23(9):1847–58.PubMedCrossRefGoogle Scholar
  32. 32.
    Bakx R, et al. Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas. Eur J Surg Oncol. 2006;32(5):520–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Tan WS, et al. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009;96(5):462–72.PubMedCrossRefGoogle Scholar
  34. 34.
    Koh PK, et al. A systematic review of the function and complications of colonic pouches. Int J Colorectal Dis. 2007;22(5):543–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Tiret E, et al. Ultralow anterior resection with intersphincteric dissection – what is the limit of safe sphincter preservation? Colorectal Dis. 2003;5(5):454–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Marr R, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242(1):74–82.PubMedCrossRefGoogle Scholar
  37. 37.
    West NP, et al. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97(4):588–99.PubMedCrossRefGoogle Scholar
  38. 38.
    West NP, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26(21):3517–22.PubMedCrossRefGoogle Scholar
  39. 39.
    Holm T, et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94(2):232–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl. 1984;66(3):192–4.PubMedGoogle Scholar
  41. 41.
    Kim TH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15(3):729–37.PubMedCrossRefGoogle Scholar
  42. 42.
    Sato H, Maeda K, Maruta M, Masumori K, Koide Y. Dis Colon Rectum. 2006;49(10 suppl); S3–12.PubMedCrossRefGoogle Scholar
  43. 43.
    Titu LV, Tweedle E, Rooney PS. High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers a systematic review. Dig Surg. 2008;25:148–157.PubMedCrossRefGoogle Scholar
  44. 44.
    Sekimoto M, Takemasa I, Mizushima T, Ikeda M, Yamanoto H, Doki Y, Mori M. Laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery. Surg endosc. 2011;25(320):861–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of SurgeryRoyal Liverpool University HospitalLiverpoolUK

Personalised recommendations